BioSpace News Archive

Marburg, Germany - July 6, 2013: Marburg Office of Swiss multinational company Novartis AG

Manufacturing

Novartis Pledges $23B Boost to US Ops as Trump Intensifies Tariff Threats

Novartis plans to build seven new facilities in the U.S., touting the creation of up to 1,000 new jobs at the company. The new facilities will include a biomedical research hub in California, two radioligand plants, and four manufacturing sites.

April 11, 2025

·

2 min read

·

Tristan Manalac

Government

Lawmakers Seek to Boost US Biotech Sector, Keep China’s Growth in Check

According to analysts at Jefferies, legislation such as the newly proposed bills that aim to streamline regulatory processes would be a positive for the biotech industry.

April 11, 2025

·

2 min read

·

Tristan Manalac

Crowd of people on United States map with American flag design.

Editorial

Biopharma Professionals Know All Too Well What Laid-Off HHS Employees Are Experiencing

Health and Human Services employees aren’t the only ones out of work. Thousands of private-sector biopharma professionals lost their jobs in the first quarter.

April 11, 2025

·

2 min read

·

Angela Gabriel

Pictured: Exterior view of the headquarters of the

FDA

FDA To Replace Some Animal Testing With AI, Human ‘Organoid’ Lab Models

Analysts at William Blair expect drug developers will continue to perform “at least some animal testing” on their investigational products. Though the process to phase out animal testing will begin “immediately,” no specific timetable was given.

April 11, 2025

·

2 min read

·

Tristan Manalac

Contemporary halftone collage. Concept of mobile apps and services, online communication, social media,rating.Business creative illustrat. Vector illustration

Policy

Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Industry Ablaze

As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, regulators and many others speak out.

April 11, 2025

·

3 min read

·

BioSpace Editorial Staff

Press Releases

Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML)

April 11, 2025

·

1 min read

Press Releases

Nature Communications Publishes Pivotal Data From Albatroz Therapeutics Demonstrating That Inhibiting Calnexin Alleviates Arthritis Symptoms and May Reverse Disease Progression